Please provide your email address to receive an email when new articles are posted on . Current allergy therapies target inflammation downstream. Revolo Biotherapeutics’ ‘1104 peptide binds to antigen ...

Understanding the mechanisms of FA: challenges remain Being able to better define the mechanisms of FA has potential direct benefits, including aiding in diagnosis and reducing patient burden related ...

Food allergy, or the aggressive immune system reaction following the consumption of a certain food or food ingredient, typically involves immunoglobulin E (IgE) antibodies and can be potentially ...

PHILADELPHIA -- Oral remibrutinib (Rhapsido) increased peanut tolerance in adults with proven allergy to it, with benefits in as little as 1 week, a phase II trial showed. After 4 weeks on the ...

Corneal disease is the primary cause of visual loss in allergic eye disease. It occurs almost exclusively in vernal keratoconjunctivitis and atopic keratoconjunctivitis. It is characterized by ...

In news that may bring hope to asthma sufferers, scientists discover a mechanism that provides a possible new target for allergy treatments. By observing the allergic response in mice with asthma, ...

Researchers identified a mechanism for why some people will itch from an allergen or mosquito bite exposure, while others will not in a new study, and showed this pathway can be targeted to prevent ...

What Is a Peanut Allergy? You have a peanut allergy when your body’s immune system overreacts to peanuts. Normally, your immune system helps protect you from germs and other harmful substances. But if ...

And climate change is only making allergy season longer and more intense. In some areas, seasonal allergies last all year.

Doctors warn common allergy pills may quietly affect appetite during hay fever season.